TrialBritish journal of haematology2022

Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial.

Sudhir Kumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.